Abstract
Cyclooxygenase-2 (COX-2) enzyme increases abnormally during excitotoxicity and cerebral ischemia and promotes neurotoxicity. Although COX-2 inhibitors could be beneficial, they have significant side effects. We and others have shown that the EP1 receptor is important in mediating PGE2 toxicity. Here, we tested the hypothesis that pretreatment with a highly selective EP1 receptor antagonist, ONO-8713, would improve stroke outcome and that post-treatment would attenuate NMDA-induced acute excitotoxicity and protect organotypic brain slices from oxygen-glucose deprivation (OGD)-induced toxicity. Male C57BL/6 mice were injected intracerebroventricularly with ONO-8713 before being subjected to 90-min middle cerebral artery occlusion (MCAO) and 96-h reperfusion. Significant reduction in infarct size was observed in groups given 0.1 (25.9 ± 4.7%) and 1.0 nmol (27.7 ± 2.8%) ONO-8713 as compared with the vehicle-treated control group. To determine the effects of ONO-8713 post-treatment on NMDA-induced excitotoxicity, mice were given a unilateral intrastriatal NMD A injection followed by one intraperitoneal injection of 10 µg/kg ONO-8713, 1 and 6 h later. Significant attenuation of brain damage (26.6 ± 4.9%) was observed at 48 h in the ONO-8713-treated group. Finally, brain slice cultures were protected (25.5 ± 2.9%) by the addition of ONO-8713 to the medium after OGD. These findings support the notion that the EP1 receptor propagates neurotoxicity and that selective blockade could be considered as a potential preventive and/or therapeutic tool against isch-emic/hypoxic neurological conditions.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Abe T, A Kunz, M Shimamura, P Zhou, J Anrather and C Iadecola (2008) The neuroprotective effect of prostaglandin E2 EP1 receptor inhibition has a wide therapeutic window, is sustained in time and is not sexually dimorphic.J. Cereb. Blood Flow Metab. doi:10.1038/jcbfm.2008.88. In press.
Adams J, Y Collaco-Moraes and J de Belleroche (1996) Cyclooxygenase-2 induction in cerebral cortex: an intracel-lular response to synaptic excitation.J. Neurochem. 66, 6–13.
Ahmad AS, H Zhuang, V Echeverria and S Doré (2006a) Stimulation of prostaglandin EP2 receptors prevents NMDA-induced excitotoxicity.J. Neurotrauma 23, 1895–1903.
Ahmad AS, S Saleem, M Ahmad and S Doré (2006b) Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage.Toxicol. Sci. 89, 265–270.
Ahmad M, S Saleem, H Zhuang, AS Ahmad, V Echeverria, A Sapirstein and S Doré (2006c) 1-HydroxyPGE1 reduces infarction volume in mouse transient cerebral ischemia. Eur.J. Neurosci. 23, 35–42.
Baron JA, RS Sandler, RS Bresalier, A Lanas, DG Morton, R Riddell, ER Iverson and DL Demets (2008) Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial.Lancet 372(9651), 1756–1764. Epub 2008 Oct 14.
Bresalier RS, RS Sandler, H Quan, JA Bolognese, B Oxenius, K Horgan, C Lines, R Riddell, D Morton, A Lanas, MA Konstam, JA Baron and the Adenomatous Polyp Prevention on Vioxx Trial I (2005) Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.N. Engl. J. Med. 352, 1092–1102.
Doré S, T Otsuka, T Mito, N Sugo, T Hand, L Wu, PD Hurn, RJ Traystman and K Andreasson (2003) Neuronal overex-pression of cyclooxygenase-2 increases cerebral infarction.Ann.Neurol. 54, 155–162.
Echeverria V, A Clerman and S Doré (2005) Stimulation of PGE2 receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following β-amyloid exposure.Eur. J. Neurosci. 22, 2199–2206.
Florea SM and LA Blatter (2008) The effect of oxidative stress on Ca2+ release and capacitative Ca2+ entry in vascular endothelial cells.Cell Calcium 43, 405–415.
Gendron TF, E Brunette, JS Tauskela and P Morley (2005) The dual role of prostaglandin E2 in excitotoxicity and precondi-tioning-induced neuroprotection.Eur. J. Pharmacol. 517, 17–27.
Graham DJ, D Campen, R Hui, M Spence, C Cheetham, G Levy, S Shoor and WA Ray (2005) Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study.The Lancet 365, 475–481.
Kawahara H, A Sakamoto, S Takeda, H Onodera, J Imaki and R Ogawa (2001) A prostaglandin E2 receptor subtype EP1 receptor antagonist (ONO-8711) reduces hyperalgesia, allo-dynia, and c-fos gene expression in rats with chronic nerve constriction.Anesth. Analg. 93, 1012–1017.
Kawano T, J Anrather, P Zhou, L Park, G Wang, KA Frys, A Kunz, S Cho, M Orio and C Iadecola (2006) Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotox-icity.Nat. Med. 12, 225–229.
Kobayashi T and S Narumiya (2002) Function of prostanoid receptors: studies on knockout mice.Prostaglandins Other Lipid Mediat. 68–69, 557–573.
Manevich Y, A Al-Mehdi, V Muzykantov and AB Fisher (2001) Oxidative burst and NO generation as initial response to ischemia in flow-adapted endothelial cells.Am. J. Physiol. Heart Circ. Physiol. 280, H2126-H2135.
Matsuo M, N Yoshida, M Zaitsu, K Ishii and Y Hamasaki (2004) Inhibition of human glioma cell growth by a PHS-2 inhibitor, NS398, and a prostaglandin E receptor subtype EP1-selective antagonist, SC51089.J. Neuro-Oncology 66, 285–292.
McCullough L, L Wu, N Haughey, X Liang, T Hand, Q Wang, RM Breyer and K Andreasson (2004) Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia.J. Neurosci. 24, 257–268.
Minami T, I Nishihara, R Uda, S Ito, M Hyodo and O Hayaishi (1994) Involvement of glutamate receptors in allodynia induced by prostaglandins E2 and F2α injected into conscious mice.Pain 57, 225–231.
Nagayama M, K Niwa, T Nagayama, ME Ross and C Iadecola (1999) The cyclooxygenase-2 inhibitor NS-398 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene.J. Cereb. Blood Flow Metab. 19, 1213–1219.
Nakayama M, K Uchimura, RL Zhu, T Nagayama, ME Rose, RA Stetler, PC Isakson, J Chen and SH Graham (1998) Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia.Proc. Natl. Acad. Sci. USA 95, 10954–10959.
Nakayama Y, K Omote, T Kawamata and A Namiki (2004a) Role of prostaglandin receptor subtype EP1 in prostaglandin E2-induced nociceptive transmission in the rat spinal dorsal horn.Brain Res. 1010, 62–68.
Nakayama Y, K Omote, T Kawamata and A Namiki (2004b) Role of prostaglandin receptor subtype EP1 in prostaglandin E2-induced nociceptive transmission in the rat spinal dorsal horn.Brain Res. 1010, 62–68.
Narumiya S, Y Sugimoto and F Ushikubi (1999) Prostanoid receptors: structures, properties, and functions.Physiol. Rev. 79, 1193–1226.
Oka K, T Oka and T Hori (1998a) PGE2 receptor subtype EP1 antagonist may inhibit central interleukin-l β-induced fever in rats.Am. J. Physiol. Regul. Integr. Comp. Physiol. 275, R1762-R1765.
Oka K, T Oka and T Hori (1998b) PGE2 receptor subtype EP1 antagonist may inhibit central interleukin-l β-induced fever in rats.Am. J. Physiol. 275, R1762-R1765.
Oka T (2004) Prostaglandin E2 as a mediator of fever: the role of prostaglandin E (EP) receptors.Front. Biosci. 9, 3046–3057.
Omote K, H Yamamoto, T Kawamata, Y Nakayama and A Namiki (2002) The effects of intrathecal administration of an antagonist for prostaglandin E receptor subtype EP1 on mechanical and thermal hyperalgesia in a rat model of postoperative pain.Anesth. Analg. 95, 1708–1712.
Sakai M, T Minami, N Hara, I Nishihara, H Kitade, Y Kamiyama, K Okuda, H Takahashi, H Mori and S Ito (1998) Stimulation of nitric oxide release from rat spinal cord by prostaglandin E2.Br. J. Pharmacol. 123, 890–894.
Saleem S, R Li, G Wei and S Doré (2007) Effects of EP1 receptor on cerebral blood flow in the middle cerebral artery occlusion model of stroke in mice.J. Neurosci. Res. 85, 2433–2440.
Salvador Moncada JPB (2006) Nitric oxide, cell bioenergetics and neurodegeneration.J. Neurochem. 97, 1676–1689.
Stock JL, K Shinjo, J Burkhardt, M Roach, K Taniguchi, T Ishikawa, HS Kim, PJ Flannery, TM Coffman, JD McNeish and LP Audoly (2001) The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure.J. Clin. Invest. 107, 325–331.
Stoppini L, PA Buchs and D Muller (1991) A simple method for organotypic cultures of nervous tissue.J. Neurosci. Meth. 37, 173–182.
Takadera T and T Ohyashiki (2006) Prostaglandin E2 deteriorates N-methyl-D-aspartate receptor-mediated cytotoxicity possibly by activating EP2 receptors in cultured cortical neurons.Life Sci. 78, 1878–1883.
Urushitani M, T Nakamizo, R Inoue, H Sawada, T Kihara, K Honda, A Akaike and S Shimohama (2001) N-methyl-D-aspartate receptor-mediated mitochondrial Ca2+ overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after Ca2+ influx.J. Neurosci. Res. 63, 377–387.
Walch L, E Clavarino and PL Morris (2003) Prostaglandin (PG) FP and EP1 receptors mediate PGF2α and PGE2 regulation of interleukin-l β expression in Leydig cell progenitors.Endocrinology 144, 1284–1291.
Watanabe K, T Kawamori, S Nakatsugi, T Ohta, S Ohuchida, H Yamamoto, T Maruyama, K Kondo, S Narumiya, T Sugimura and K Wakabayashi (2000) Inhibitory effect of a prostaglandin E receptor subtype EP(1) selective antagonist, ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice.Cancer Lett. 156, 57–61.
Zhou P, L Qian, T Chou and C Iadecola (2008) Neuroprotection by PGE2 receptor EP1 inhibition involves the PTEN/AKT pathway.Neurobiol. Dis. 29, 543–551.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ahmad, A.S., Kim, Y.T., Ahmad, M. et al. Selective blockade of PGE2 EP1 receptor protects brain against experimental ischemia and excitotoxicity, and hippocampal slice cultures against oxygen-glucose deprivation. neurotox res 14, 343–351 (2008). https://doi.org/10.1007/BF03033858
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF03033858